Research.Patient.info
chronic Graft-versus-Host-Disease (cGvHD) research hub
2 indexed studies · 0 currently recruiting
- authorisedHuman Pharmacology (Phase I)- Other
A multiCenter phase I study of aUtologous CD19 CAR T cElls for therapy refractory chronic GvHD (CURE-cGvHD)
This study looks at a new treatment called CAR T-cells for people with a serious condition called chronic Graft-versus-Host Disease (cGvHD). This condition can happen after a stem cell transplant. The trial aims to see if this new treatment is safe and how it works.
Germany - ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)
This study is looking at a medicine called ibrutinib for children and young people with chronic Graft Versus Host Disease (cGVHD). It aims to find the right dose and check how safe and effective it is for those aged 1 to 22 years.
France · Italy · Spain